Literature DB >> 29916484

EUS diagnosis of cystic pancreatic neuroendocrine tumors.

Tony Li-Geng1, Guoping Cai2, Harry R Aslanian3.   

Abstract

Entities:  

Keywords:  CEA, carcinoembryonic antigen; IV, intravenous; MRI, magnetic resonance imaging; pNETs, pancreatic neuroendocrine tumors.

Year:  2018        PMID: 29916484      PMCID: PMC6004037          DOI: 10.1016/j.vgie.2017.12.007

Source DB:  PubMed          Journal:  VideoGIE        ISSN: 2468-4481


× No keyword cloud information.
EUS-guided FNA (EUS-FNA) is an important technique for the assessment of pancreatic cysts. Pancreatic neuroendocrine tumors (pNETs) are rare lesions that can be solid or cystic. Cystic pNETs account for 10% to 18% of resected pNETs2, 3 and 7% to 10% of all pancreatic neoplasms.4, 5, 6 Most cystic pNETs are nonfunctional and can present a diagnostic challenge to the radiologist and endosonographer. Endosonographically, cystic pNETs often have thickened walls and septations.7, 8 Wall thickening, low carcinoembryonic antigen (CEA) levels, and diagnostic cytologic features are found significantly more frequently in patients with cystic pNETs than in patients with mucinous cysts. Targeted cyst wall puncture and aspiration during EUS-FNA increases the diagnostic yield.7, 8 Other notable characteristics of pNET are described in Table 1.9, 10
Table 1

Findings on EUS-FNA characteristics of cystic pNETs

StudyLocationDiameter (range)Wall thickening (>2 mm thick)SeptationCyst fluid CEA level (range)Cytologic diagnosis of NET
Ho et al, 2013963.0% body/tailMedian 35 mm (8-80)48.1% of cases reported81.5% of casesMedian 1.25 ng/mL (0.6-500)71.0%
Yoon et al, 20131073.7% body/tailMedian 24 mm (13-70)57.9% of cases reported42.1% of casesMedian 1.1 ng/mL (0.3-500)68.4%

CEA, Carcinoembryonic antigen; pNETs, pancreatic neuroendocrine tumors.

Findings on EUS-FNA characteristics of cystic pNETs CEA, Carcinoembryonic antigen; pNETs, pancreatic neuroendocrine tumors. The aim of this video case series is to demonstrate the endosonographic appearances of cystic pNET and EUS-FNA techniques to optimize the diagnosis of cystic pNET (Video 1, available online at www.VideoGIE.org). A thickened cyst wall and septations should raise suspicion for a cystic neuroendocrine tumor. Cyst fluid may have low cellularity, and CEA levels are typically low. The cyst wall and septations should be targeted with FNA to maximize cytologic diagnosis.

Cases

Patient 1

A 60-year-old man presented for elective outpatient upper EUS. The patient had a history of hepatitis C and was referred for abdominal CT scan (Fig. 1A) to evaluate abnormal liver function test results and abdominal pain. A cystic and solid mass was detected in the body of the pancreas. On EUS, a 2.8-cm × 2.5-cm cystic and solid mass with a few small vessels in the superior portion was identified in the body of the pancreas. After a Doppler study confirmed the absence of flow in the needle path, 2 passes were made with a 25-gauge needle to sample the cyst wall (Fig. 2A). On-site cytologic analysis identified single and dyscohesive groups of tumor cells with eccentrically located nuclei in a bloody background, suggestive of cystic pNET (Figs. 3A and B).
Figure 1

A, Patient 1: abdominal CT with a 2.8-cm cystic and solid pancreas mass. B, Patient 2: abdominal MRI with a 1.2-cm pancreas cyst. C, Patient 3: abdominal CT with a 3-cm pancreas cyst. D, Patient 4: abdominal CT with a 2-cm pancreas cyst. E, Patient 5: abdominal CT with a 1.2-cm pancreas cyst. MRI, magnetic resonance imaging.

Figure 2

A, Patient 1: FNA targeting thickened cyst wall. B, Patient 2: FNA targeting thickened cyst wall and septations. C, Patient 3: FNA targeting thickened portion of cystic/solid lesion. D, Patient 4: FNA targeting septations of multi-septated cyst. E, Patient 5: second-pass FNA targeting thickened wall of cyst with self-limited hemorrhage.

Figure 3

On-site cytologic view of sample from patient 1 showing dyscohesive groups of tumor cells and eccentrically located nuclei in a bloody background. Some tumor cells have fine cytoplasmic vacuoles. A few histiocytes are also present (Diff-Quik stain, orig. mag. ×200 and ×400).

A, Patient 1: abdominal CT with a 2.8-cm cystic and solid pancreas mass. B, Patient 2: abdominal MRI with a 1.2-cm pancreas cyst. C, Patient 3: abdominal CT with a 3-cm pancreas cyst. D, Patient 4: abdominal CT with a 2-cm pancreas cyst. E, Patient 5: abdominal CT with a 1.2-cm pancreas cyst. MRI, magnetic resonance imaging. A, Patient 1: FNA targeting thickened cyst wall. B, Patient 2: FNA targeting thickened cyst wall and septations. C, Patient 3: FNA targeting thickened portion of cystic/solid lesion. D, Patient 4: FNA targeting septations of multi-septated cyst. E, Patient 5: second-pass FNA targeting thickened wall of cyst with self-limited hemorrhage. On-site cytologic view of sample from patient 1 showing dyscohesive groups of tumor cells and eccentrically located nuclei in a bloody background. Some tumor cells have fine cytoplasmic vacuoles. A few histiocytes are also present (Diff-Quik stain, orig. mag. ×200 and ×400).

Patient 2

A 75-year-old man presented for elective outpatient EUS. The patient had a left lower lobe infiltrate and a history of tobacco use and chronic obstructive pulmonary disease and was referred for magnetic resonance imaging (MRI) of the chest (Fig. 1B). A pancreas cyst was incidentally detected, and MRI of the abdomen was performed. A 1.2-cm cyst was identified on the tail of the pancreas. On EUS, the 1.6-cm × 1.1-cm cyst was thick-walled with central anechoic areas, a few septations, and a 0.3- to 0.5-cm hypoechoic rim around the lesion. After Doppler study, sampling of the cyst wall was performed with a 25-gauge needle (Fig. 2B). On-site cytologic analysis identified cells suggestive of cystic pNET. A second pass was made with a 25-gauge needle for cell block.

Patient 3

A 61-year-old man who had previously undergone a gastrectomy presented for elective outpatient EUS. The patient had right flank pain and hematuria and was referred for CT scan of the abdomen for renal stones. A 3-cm cyst in the tail of the pancreas was incidentally detected (Fig. 1C). On EUS, there was a 2.5-cm unilocular cyst in the pancreas tail, with a 1.5-cm × 2-cm cystic and solid lesion with thick central components (Fig. 2C). Small vessels coursed superior to the lesion. One pass was made with a 25-gauge needle into the superior solid portion (Fig. 2C). On-site cytologic analysis identified cells suggestive of cystic pNET. A second pass was made with a 22-gauge needle for cell block.

Patient 4

A 60-year-old man presented for EUS. The patient had low back pain and was referred for abdominal CT (Fig. 1D). An abnormal, hyperenhancing, multiseptated 2-cm cystic lesion was incidentally detected in the body of the pancreas. On EUS, a 2-cm cyst with thick septations was seen adjacent to an elongated pancreas side-branch that extended to the cyst. One pass of the thickened septations (Fig. 2D) was made with a 25-gauge needle. On-site cytologic analysis identified cells suggestive of cystic pNET. A second pass was made with a 22-gauge needle, yielding nonviscous, blood-tinged fluid.

Patient 5

A 63-year-old man with a history of melanoma presented for EUS. A 1.2-cm cyst was incidentally detected in the head of the pancreas on CT of the abdomen (Fig. 1E) for restaging of melanoma. On EUS, a unilocular 1.4-cm × 1.1-cm cyst with a 1.7-mm-thick wall and small debris within was seen in the head and neck of the pancreas. One pass was made with a 25-gauge needle of the cyst wall (Fig. 2E). On-site cytologic analysis identified cells suggestive of cystic pNET. After FNA, there was a self-limited hemorrhage within the cyst, seen as hyperechoic material. A second pass was made with a 22-gauge needle, yielding scant, blood-tinged aspirate that was placed in wash.

Conclusions and learning objectives

Prophylactic intravenous (IV) antibiotics (such as 400 mg IV ciprofloxacin) are given before EUS-FNA of cystic lesions. On EUS, thickened pancreas cyst walls and septations should raise a suspicion of cystic pNET. Doppler study can be used to identify and avoid blood vessels and the pancreas duct at the time of EUS-FNA, and thickened walls and septations should be targeted to maximize cytologic diagnosis. FNA with 25-gauge or 22-gauge needles provides a cellular sample of thickened walls for onsite review, which can confirm a suspicion of cystic pNET. Full (10 mL) suction or capillary technique, which consists of slowly removing the stylet while moving the needle at the target site, can be used to sample thickened cyst walls or septations. If the cellularity of the aspirate is low, 10 mL of suction may be used. Twenty-two–gauge needles with suction applied may be used to aspirate the cyst fluid in combination with targeting the wall. Cystic pNETs typically have low cyst fluid CEA levels.

Disclosure

All authors disclosed no financial relationships relevant to this publication.
  11 in total

1.  Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions.

Authors:  Jean Louis Frossard; Paul Amouyal; Gilles Amouyal; Laurent Palazzo; Juan Amaris; Manuela Soldan; Emiliano Giostra; Laurent Spahr; Antoine Hadengue; Monique Fabre
Journal:  Am J Gastroenterol       Date:  2003-07       Impact factor: 10.864

Review 2.  Cystic neoplasms of the pancreas.

Authors:  William R Brugge; Gregory Y Lauwers; Dushyant Sahani; Carlos Fernandez-del Castillo; Andrew L Warshaw
Journal:  N Engl J Med       Date:  2004-09-16       Impact factor: 91.245

3.  851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital.

Authors:  Nakul P Valsangkar; Vicente Morales-Oyarvide; Sarah P Thayer; Cristina R Ferrone; Jennifer A Wargo; Andrew L Warshaw; Carlos Fernández-del Castillo
Journal:  Surgery       Date:  2012-07-06       Impact factor: 3.982

4.  Targeted cyst wall puncture and aspiration during EUS-FNA increases the diagnostic yield of premalignant and malignant pancreatic cysts.

Authors:  Shih-Kuang S Hong; David E Loren; Jason N Rogart; Ali A Siddiqui; Jocelyn A Sendecki; Marluce Bibbo; Robert M Coben; Daniel P Meckes; Thomas E Kowalski
Journal:  Gastrointest Endosc       Date:  2012-02-07       Impact factor: 9.427

5.  Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT.

Authors:  Satomi Kawamoto; Pamela T Johnson; Chanjuan Shi; Aatur D Singhi; Ralph H Hruban; Christopher L Wolfgang; Barish H Edil; Elliot K Fishman
Journal:  AJR Am J Roentgenol       Date:  2013-03       Impact factor: 3.959

Review 6.  Antibiotic prophylaxis for GI endoscopy.

Authors:  Mouen A Khashab; Krishnavel V Chithadi; Ruben D Acosta; David H Bruining; Vinay Chandrasekhara; Mohamad A Eloubeidi; Robert D Fanelli; Ashley L Faulx; Lisa Fonkalsrud; Jenifer R Lightdale; V Raman Muthusamy; Shabana F Pasha; John R Saltzman; Aasma Shaukat; Amy Wang; Brooks D Cash
Journal:  Gastrointest Endosc       Date:  2014-11-11       Impact factor: 9.427

7.  Cyst wall puncture and aspiration during EUS-guided fine needle aspiration may increase the diagnostic yield of mucinous cysts of the pancreas.

Authors:  Jason N Rogart; David E Loren; Bheema S Singu; Thomas E Kowalski
Journal:  J Clin Gastroenterol       Date:  2011-02       Impact factor: 3.062

8.  Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible?

Authors:  Steven A Ahrendt; Richard A Komorowski; Michael J Demeure; Stuart D Wilson; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2002 Jan-Feb       Impact factor: 3.452

9.  Cystic pancreatic neuroendocrine tumors: endoscopic ultrasound and fine-needle aspiration characteristics.

Authors:  W J Yoon; E S Daglilar; M B Pitman; W R Brugge
Journal:  Endoscopy       Date:  2013-01-07       Impact factor: 10.093

10.  Endosonographic and cyst fluid characteristics of cystic pancreatic neuroendocrine tumours: a multicentre case series.

Authors:  Henry C Ho; Mohamad A Eloubeidi; Uzma D Siddiqui; William R Brugge; Federico Rossi; Brenna W Bounds; Harry R Aslanian
Journal:  Dig Liver Dis       Date:  2013-04-09       Impact factor: 4.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.